Efficacy and Safety of SGLT2 Inhibitors as Adjunctive Treatment in Type 1 Diabetes in a Tertiary Care Center in Saudi Arabia

Background  Adjunctive treatment with sodium-glucose co-transporters 2 inhibitors (SGLT2- I) has been successfully used in patients with type 1 diabetes mellitus (T1DM) in recent years to improve glycemic control and reduce body weight without increasing the risk of hypoglycemia; however, there is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fallatah, Walla, Brema, Imad, Alobedallah, Ahmed, Alkhathami, Reem, Zaheer, Shawana, AlMalki, Eyad, Almehthel, Mohammed, Alzahrani, Saad, AlMalki, Mussa H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110106/
https://www.ncbi.nlm.nih.gov/pubmed/35586391
http://dx.doi.org/10.1055/s-0041-1742196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110106/
https://www.ncbi.nlm.nih.gov/pubmed/35586391
http://dx.doi.org/10.1055/s-0041-1742196

Ejemplares similares